Drugs / IntragamP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00405184 | May 2007 → Jul 2008 | immunodeficiency disease | CSL Limited | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IntragamP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00405184 ↗ |
| Route | Intravenous | “IntragamP to be administered intravenously.” NCT00405184 ↗ |